Jaguar Health Stock Surges Friday: What's Happening?

Jaguar Health Inc. (NASDAQ: JAGX) saw its stock surge by 47.59% to $10.42 on Friday, reversing a previous sell-off driven by dilution concerns. The increase follows the company's announcement of additional debt-for-equity exchanges that reduced its outstanding debt by over $6.7 million, including the full retirement of a major promissory note issued to Streeterville Capital. This debt reduction is crucial for the biopharmaceutical firm as it aims to support the commercialization of its FDA-approved treatment, Mytesi, and fund clinical trials for new indications.